NFKB1 and myeloid sarcoma: Further studies revealed comparable degrees of demyelination and remyelination between IKKβOligo−KO and control in both EAE and cuprizone models, suggesting that NF-κB in oligodendrocytes is dispensable for myelin loss in patients with MS.